Somatropin (Lilly)

生长激素（礼来）

Report date: 2022/09/07 17:52:04

Base Information

Drug NameSomatropin (Lilly)
Drug Alias NameSomatropine (rDNA origin, Lilly)生长激素类（礼来）重组人生长激素（礼来）Recombinant human growth hormone (rDNA origin, Lilly)促生长激素（礼来） +[11] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyIdiopathic short statureFailure to Thrive +[13] 
Global Approved IndicationsGrowth hormone deficiencyIdiopathic short statureGrowth Disorders +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1986/10/16
Country/TerritoryUnited StatesItalyGermany +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentColumbia UniversityNational Human Genome Research Institute
Active IndicationsGrowth hormone deficiencyIdiopathic short statureGrowth Disorders +[6] 
Inactive IndicationsFailure to ThriveCystinosisPremature Birth +[7] 

Other Information

ATC CodeH01AC01
Related LinksDrugBankKEGG